|
|
Pharmala Biotech Holdings Inc
CSE •
Healthcare •
Biotechnology •
Quote as of 09/11/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCSE
Market Capitalization30.04 mln
Earnings Date08/05/2025
Beneish M-Score
-1.09
Manipulation likely
Pre-Tax Margin
-127%
Severely loss-making
Key Fundamentals
EPS-0.01
ROE-68.81
ROIC-71.13
ROA-48.32
EBITDA, mln-1.47
EV / EBITDA-16.92
EV / EBIT-15.66
Revenue, mln1.27
EV / Revenue19.64
Financial Strength
Altman Z-Score8.4
Piotroski F-Score
4
/ 9
Beneish M-Score-1.09
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
44.44% |
98
/ 100
 |
| 1 Month |
91.18% |
97
/ 100
|
| 2 Months |
103% |
96
/ 100
|
| 6 Months |
195% |
98
/ 100
|
| 1 Year |
210% |
82
/ 100
 |
|
| |
